Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMSA6IY)
| Drug Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
								Arecaidine propargyl ester; 35516-99-5; NCGC00015006-01; Lopac-A-140; AC1L1D7L; AC1Q62JO; Lopac0_000136; GTPL295; CHEMBL128365; SCHEMBL13184690; CTK1B6885; CHEBI:92418; DTXSID30274358; SPHRJZBOFYIKMC-UHFFFAOYSA-N; prop-2-ynyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate; 2-Propynyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate; ZINC25720839; AKOS030566155; CCG-204231; NCGC00015006-03; NCGC00162072-01; NCGC00015006-04; NCGC00162072-02; NCGC00015006-02; L000114; BRD-K23922020-075-01-1; prop-2-ynyl 1-methyl-5,6-dihydro-2H-pyridin
								
							 | |||||||||||||||||||
| Indication | 
 | |||||||||||||||||||
| Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
|  Drug Therapeutic Target (DTT) | 
 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||
| Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||
References
